Interleukin-10 appearance following thoraco-abdominal and abdominal aortic aneurysm repair is associated with the duration of visceral ischaemia

European Journal of Vascular and Endovascular Surgery

Volumn 20, Issue 2, 2000, Pages 169-172

  Oldenburg, H S A ^a   Burress Welborn, M ^b   Pruitt, J H ^b   Boelens, P G ^a   Seeger, J M ^b   Martin, T D ^b   Wesdorp, R I C ^a   Rauwerda, J A ^a   Van Leeuwen, P A M ^a   Moldawer, L L ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aortic aneurysm; IL 10; Visceral ischaemia

Indexed keywords

INTERLEUKIN 10;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; AORTA CLAMPING; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ISCHEMIA; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORACIC AORTA ANEURYSM;

EID: 0033845684     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2000.1147     Document Type: Article

References (24)

1. Complications of standard elective abdominal aortic aneurysm repair
2. The management of thoracoabdominal aneurysms
3. Thoracoabdominal aneurysm repair: A representative experience
4. Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping. Risk factors and late results
5. Evolving experience with thoracoabdominal aortic aneurysm repair at a single institution
6. Visceral ischemia and organ dysfunction after thoracoabdominal aortic aneurysm repair
7. Incidence and clinical presentation of bowel ischaemia after aortoiliac surgery - 2930 operations from a population-based registry in Sweden
8. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion
9. Tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-8 (IL-8) are released following thoracoabdominal aneurysm repair and TNF-α levels are related to patient outcome
10. Interleukin-10
11. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
12. Role of IL-10 in inflammation. Studies using cytokine knockout mice
13. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion
14. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury
15. Endogenous IL-10 protects mice from death during septic peritonitis
16. Cytokine and fibrinogen response in patients undergoing open abdominal aortic aneurysm surgery
17. Interleukin-10 production during septicaemia
18. Tumour necrosis factor-α and interleukin-10 production in septic patients and the regulatory effect of plasma
19. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock
20. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection
21. Interleukin-10 as a regulatory cytokine induced by cellular stress: Molecular aspects
22. Interleukin-10 protects mice against Staphylococcal enterotoxin B-induced lethal shock
23. Therapeutic implications of interleukin-10 in surgical disease
24. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumour necrosis factor-dependent murine model of acute visceral ischemia